COO  Cooper Companies Inc. (The)

Exchange

NYSE

Sector

Health Care

Industry

Ophthalmic Goods

Market Cap.

8.060B

Vuru Grade

53.13/100

Current Price

$166.93
-2.39 (-1.41%)

Growth Price

$107.85
Overvalued by 35.39%

Stability Price

$21.17
Overvalued by 87.32%

Company Metrics

  • 28.06 P/E
  • 4.92 P/S
  • 3.08 P/B
  • 6.035 EPS
  • 8.09% Cash ROIC
  • 0.24 Cash Ratio
  • 0.06 / 0.04% Dividend
  • 531,349.00 Avg. Vol.
  • 48.28M Shares
  • 8.060B Market Cap.

Company Description

The Cooper Companies, Inc., through its subsidiaries, develops, manufactures, and markets healthcare products serving the vision care and women's healthcare markets worldwide. It offers a range of soft contact lenses for the vision care market, such as toric lenses, which correct astigmatism; multifocal lenses for presbyopia; and spherical lenses that correct the common visual defects. The company...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

The Cooper Companies Up to Strong Buy on Higher Outlook
Zacks.com - Sep 12, 2014
During the quarter, The Cooper Companies announced its acquisition of Sauflon Pharmaceuticals - a European manufacturer and distributor of soft contact lenses and solutions.
The Cooper Companies' Women's Healthcare Unit Acquires EndoSee
GlobeNewswire (press release) - Oct 8, 2014
PLEASANTON, Calif., Oct. 8, 2014 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women's healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable ...
The Cooper Companies, Inc. (COO) news: The Cooper Companies ...
Seeking Alpha - Mar 7, 2014
The Cooper Companies Management Discusses Q1 2014 Results - Earnings Call Transcript. Mar. 6, 2014 9:40 PM ET | About: The Cooper Companies Inc. (COO) by: SA Transcripts. The Cooper Companies (NYSE:COO). Q1 2014 Earnings Call. March 06 ...
The Cooper Companies Acquires EndoSee for $44 Million
Zacks.com - Oct 9, 2014
The Cooper Companies Inc. (COO - Analyst Report) revealed that its women's healthcare unit - CooperSurgical - has acquired EndoSee Corporation for approximately $44 million.
The Cooper Companies Acquires EndoSee for $44 Million - Analyst Blog - NASDAQ
The Cooper Companies Announces Release Date for Fourth Quarter and Full ...
Nasdaq - Nov 4, 2014
PLEASANTON, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced it will release fourth quarter and full year 2014 financial results on Thursday, December 4, 2014, at 4:00 PM ET.
Up 8%: Does Cooper Companies Inc's Buyout Make Sense?
Motley Fool - Jul 1, 2014
Eye care specialist Cooper Companies (NYSE: COO ) is getting into the med-tech merger game and not just as a "me too" player.
Cooper Companies - What To Look For After The $1.2 Billion Sauflon Deal - Seeking Alpha
Cooper Companies Acquires Contact Lens Maker - Zacks.com
The Cooper Companies Upped to Buy
Zacks.com - Jul 7, 2014
The Cooper Companies has been enjoying rising estimate revisions in the past 30 days with nine upward estimate revisions and no downward revision for 2014.
The Cooper Companies Announces Release Date for Third Quarter 2014
GlobeNewswire (press release) - Aug 4, 2014
PLEASANTON, Calif., Aug. 4, 2014 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced it will release third quarter 2014 financial results on Thursday, September 4, 2014, at 4:00 PM ET.
The Cooper Companies Misses on Q3 Earnings, Revenues
Zacks.com - Sep 5, 2014
The Cooper Companies Inc. (COO - Analyst Report) posted a 9.2% rise in adjusted earnings per share for fiscal 2014-third-quarter (ended Jul 31, 2014) to $1.90 from the year-ago level of $1.74 but missed the Zacks Consensus Estimate by a penny.
The Cooper Companies Announces Third Quarter 2014 Results - Yahoo!7 News
The Cooper Companies Misses on Q3 Earnings, Revenues - Analyst Blog - NASDAQ
The Cooper Companies Continues to Grow on Strong Lens Market
Zacks.com - Aug 28, 2014
On Aug 27, we have updated our research report on The Cooper Companies Inc. (COO - Analyst Report). We are encouraged by the company's upgraded earnings guidance and stable revenues outlook for fiscal 2014.